In aftermath of FDA GRAS shift, FloraWorks continues regulatory path for cannabinol
Portland-based cannabinoid therapeutic company FloraWorks is seeking new dietary ingredient status for TruCBN, its proprietary cannabinol isolate.
Read the full article on the original site.
Read Full Article